Hana Pharm Co., Ltd.

KRX:293480.KS

11350 (KRW) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

202320222021202020192018201720162015
Assets:
Current Assets:
Cash & Cash Equivalents 1,424.61612,548.1076,615.20920,546.42614,984.52916,988.45812,940.2321,388.813568.072
Short Term Investments 4,734.1755,034.17650,251.15452,83074,424.59789,322.5213,5501,7703,098
Cash and Short Term Investments 6,158.79117,582.28356,866.36373,376.42689,409.126106,310.97916,490.2323,158.8133,666.072
Net Receivables 46,167.0244,457.57742,838.25543,626.11542,518.05243,162.68243,059.89839,290.39630,764.369
Inventory 48,347.32341,403.56640,692.71930,729.9426,886.02522,006.03919,269.93418,026.63414,385.792
Other Current Assets 1,747.78383.79757.63261.94674.8392.07843,638.017-01,392.177
Total Current Assets 102,420.917103,527.223140,454.968147,794.427158,888.033171,571.77879,398.18360,475.84350,208.411
Non-Current Assets:
Property, Plant & Equipment, Net 157,841.187151,868.053122,398.71293,073.60578,275.3846,313.80346,653.10449,663.62738,209.861
Goodwill 000000000
Intangible Assets 14,402.18511,990.06512,837.4497,974.7575,479.9765,319.3763,383.741,986.2420
Goodwill and Intangible Assets 14,402.18511,990.06512,837.4497,974.7575,479.9765,319.3763,383.741,986.2420
Long Term Investments 68,963.15824,804.576-39,371.628-44,891.556-71,773.824-86,824.462-1,103.481696.626772.457
Tax Assets 964.249-24,804.57667,129.40572,576.688372.198105,921.59502,451.9970
Other Non-Current Assets 3,794.48778,579.21548.34851.38491,792.03177.57813,219.228-681.9973,064.203
Total Non-Current Assets 245,965.265242,437.333163,042.286128,784.877104,145.7670,807.8962,152.59154,116.49542,046.521
Total Assets 348,386.182345,964.556303,497.254276,579.304263,033.794242,379.668141,550.774114,592.33892,254.932
Liabilities & Equity:
Current Liabilities:
Account Payables 6,447.4988,063.5456,677.6176,032.4076,938.4156,329.7657,351.8846,920.9256,331.515
Short Term Debt 24,934.21911,967.3769,545.1383,602.5083,682.2993,080.99522,831.2589,779.0288,753.877
Tax Payables 2,832.7586,306.7756,251.3936,130.347,458.3296,367.3936,979.2515,553.3124,961.736
Deferred Revenue 186.424202.6722,161.3722,280.03120,872.7096,367.39318,529.72717,395.1544,961.736
Other Current Liabilities 24,558.24124,470.4642,460.7742,322.5372,164.61713,849.5020.001-0.0019,890.31
Total Current Liabilities 56,126.38244,704.05540,844.89934,237.48333,658.0429,627.65448,712.8734,095.10629,937.438
Non-Current Liabilities:
Long Term Debt 1,598.84622,132.3461,229.649896.5941,772.551,568.2746,214.1721,154.5526,389.27
Deferred Revenue Non-Current 7476.36473.364663.364729.602333.5614,113.12,393.8280
Deferred Tax Liabilities Non-Current -74588.056503.715313.555,085.515456.6841,213.1071,464.2372,176.851
Other Non-Current Liabilities 12,676.06510,066.8158,944.5438,086.7991,456.5265,007.813-0.001-0.0011,480.419
Total Non-Current Liabilities 14,274.91132,863.58110,751.2719,960.3089,044.1937,366.33311,540.37725,012.61530,046.54
Total Liabilities 70,401.29477,567.63651,596.17144,197.79142,702.23236,993.98760,253.24659,107.72159,983.977
Equity:
Preferred Stock 000000000
Common Stock 8,886.4738,886.4738,886.4738,1008,1008,1006,059.274,872.4393,705.5
Retained Earnings 166,628.863159,224.09143,064.26123,421.038114,131.97591,284.03369,506.40845,957.64813,059.918
Accumulated Other Comprehensive Income/Loss 8,927.90510,928.9129,710.638,966.9633,917.9113,867.1274,932.2036,953.67813,705.311
Other Total Stockholders Equity 93,541.64789,357.44690,239.7291,893.51194,181.676102,134.521441.797-2,299.1481,800.226
Total Shareholders Equity 277,984.889268,396.921251,901.084232,381.512220,331.561205,385.68180,939.67955,484.61732,270.954
Total Equity 277,984.889268,396.921251,901.084232,381.512220,331.561205,385.68181,297.52755,484.61732,270.954
Total Liabilities & Shareholders Equity 348,386.182345,964.556303,497.254276,579.304263,033.794242,379.668141,550.774114,592.33892,254.932